4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001140361-18-018863
President & CEO acquired 27,007 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Murray Mark J. · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-17 | Exercise or conversion : show line 1 in the form | +27,007 | $0.35 | $9,560 | 316,396 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-04-16 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +418,187 | 418,187 | D |
| 2018-04-17 | Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) | −27,007 | 0 | D |
Loading xslF345X03/doc1.xml…